New Histamine H2-Receptor Antagonist Pibutidine Hydrochloride. Clinical Study of Pibutidine Hydrochloride(IT-066) on Peptic Ulcer: Early Dose Finding by Open Study.

Accession number;99A0731601
Title;New Histamine H2-Receptor Antagonist Pibutidine Hydrochloride. Clinical Study of Pibutidine Hydrochloride(IT-066) on Peptic Ulcer: Early Dose Finding by Open Study.
Author; KOBAYASHI KENZO (Osaka City Univ., Med. Sch.) TAKEMOTO TADAYOSHI (Tokyo Women's Medical College, Inst. of Adult Diseases) NAMIKI MASAYOSHI (Asahikawa Med. Coll.) ASAKA MASAHIRO (Hokkaido Univ., Sch. of Med.) MASAMUNE KEN (Akita Univ., Sch. of Med.) ASAKI SHIGERU (Tohoku Univ., Sch. of Med.) SEKIGUCHI TOSHIKAZU (Gunma Univ., Sch. of Med.) YAMAGATA SUSUMU (Univ. of Tsukuba, Inst. of Clin. Med.) SHIBUE TADASHI (Kagoshimaken Kosei Nogyo Kyodo Kumiai Rengokai Kenko Kanri Senta)
Journal Title;Japanese Pharmacology & Therapeutics
Journal Code:Z0947A
ISSN:0386-3603
VOL.27;NO.Suppl.4;PAGE.S.991-S.1008(1999)
Figure&Table&Reference;FIG.5, TBL.12, REF.9
Pub. Country;Japan
Language;Japanese
Abstract;